A Randomized Controlled Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial.

Trial Profile

A Randomized Controlled Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Sep 2014

At a glance

  • Drugs Everolimus (Primary) ; Paclitaxel
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms COMPARE; COMPARE 1
  • Most Recent Events

    • 05 Apr 2011 Pooled analysis results presented at the 60th Annual Scientific Session of the American College of Cardiology.
    • 05 Apr 2011 Two-year results of a patient-level pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented at the 60th Annual Scientific Session of the American College of Cardiology.
    • 21 Sep 2010 Results of 2-year follow-up were presented in an abstract at the Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top